Aims The myocardial ischaemia/reperfusion (I/R) injury is almost inevitable since reperfusion is the only established treatment for acute myocardial infarction (AMI). To date there is no effective strategy available for reducing the I/R injury. Our aim was to elucidate the mechanisms underlying myocardial I/R injury and to develop a new strategy for attenuating the damage it causes. Methods and results Using a mouse model established by ligation of left anterior descending artery, we found an increase in activity of protein tyrosine phosphatases (PTPs) in myocardium during I/R. Treating the I/R-mice with a pan-PTP inhibitor phenyl vinyl sulfone attenuated I/R damage, suggesting PTP activation to be harmful in I/R. Through analysing RNAseq data, we showed PTPs being abundantly expressed in mouse myocardium. By exposing primary cardiomyocytes ablated with specific endogenous PTPs by RNAi to hypoxia/reoxygenation (H/R), we found a role that PTP-PEST (PTPN12) plays to promote cell death under H/R stress. Auranofin, a drug being used in clinical practice for treating rheumatoid arthritis, may target PTP-PEST thus suppressing its activity. We elucidated the molecular basis for Auranofin-induced inactivation of PTP-PEST by structural studies, and then examined its effect on myocardial I/R injury. In the mice receiving Auranofin before reperfusion, myocardial PTP activity was suppressed, leading to restored phosphorylation of PTP-PEST substrates, including ErbB-2 that maintains the survival signalling of the heart. In line with the inhibition of PTP-PEST activity, the Auranofin-treated I/R-mice had smaller infarct size and better cardiac function. Conclusions PTP-PEST contributes to part of the damages resulting from myocardial I/R. The drug Auranofin, potentially acting through the PTP-PEST-ErbB-2 signalling axis, reduces myocardial I/R injury. Based on this finding, Auranofin could be used in the development of new treatments that manage I/R injury in patients with AMI.
As the color filter array (CFA)2.0, the RGBW CFA pattern, in which each CFA pixel contains only one R, G, B, or W color value, provides more luminance information than the Bayer CFA pattern. Demosaicking RGBW CFA images I R G B W is necessary in order to provide high-quality RGB full-color images as the target images for human perception. In this letter, we propose a three-stage demosaicking method for I R G B W . In the first-stage, a cross shape-based color difference approach is proposed in order to interpolate the missing W color pixels in the W color plane of I R G B W . In the second stage, an iterative error compensation-based demosaicking process is proposed to improve the quality of the demosaiced RGB full-color image. In the third stage, taking the input image I R G B W as the ground truth RGBW CFA image, an I R G B W -based refinement process is proposed to refine the quality of the demosaiced image obtained by the second stage. Based on the testing RGBW images that were collected from the Kodak and IMAX datasets, the comprehensive experimental results illustrated that the proposed three-stage demosaicking method achieves substantial quality and perceptual effect improvement relative to the previous method by Hamilton and Compton and the two state-of-the-art methods, Kwan et al.’s pansharpening-based method, and Kwan and Chou’s deep learning-based method.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.